nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—SLC15A2—choroid plexus—germ cell cancer	0.0513	0.568	CbGeAlD
Cefuroxime—Haemoglobin—Bleomycin—germ cell cancer	0.00459	0.00505	CcSEcCtD
Cefuroxime—Haemorrhage—Bleomycin—germ cell cancer	0.00457	0.00502	CcSEcCtD
Cefuroxime—Dysuria—Ifosfamide—germ cell cancer	0.00456	0.00501	CcSEcCtD
Cefuroxime—Blood creatinine increased—Cisplatin—germ cell cancer	0.00456	0.00501	CcSEcCtD
Cefuroxime—Agranulocytosis—Dactinomycin—germ cell cancer	0.00443	0.00487	CcSEcCtD
Cefuroxime—Cramp muscle—Cisplatin—germ cell cancer	0.00438	0.00482	CcSEcCtD
Cefuroxime—Infestation—Ifosfamide—germ cell cancer	0.00435	0.00478	CcSEcCtD
Cefuroxime—Infestation NOS—Ifosfamide—germ cell cancer	0.00435	0.00478	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00431	0.00474	CcSEcCtD
Cefuroxime—Renal failure—Ifosfamide—germ cell cancer	0.00427	0.0047	CcSEcCtD
Cefuroxime—Hepatitis—Dactinomycin—germ cell cancer	0.00426	0.00468	CcSEcCtD
Cefuroxime—Stomatitis—Ifosfamide—germ cell cancer	0.00424	0.00466	CcSEcCtD
Cefuroxime—Leukopenia—Vinblastine—germ cell cancer	0.00421	0.00463	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00411	0.00452	CcSEcCtD
Cefuroxime—Musculoskeletal stiffness—Methotrexate—germ cell cancer	0.0041	0.00451	CcSEcCtD
Cefuroxime—Chills—Bleomycin—germ cell cancer	0.0041	0.0045	CcSEcCtD
Cefuroxime—Convulsion—Vinblastine—germ cell cancer	0.00408	0.00448	CcSEcCtD
Cefuroxime—Agranulocytosis—Ifosfamide—germ cell cancer	0.00406	0.00446	CcSEcCtD
Cefuroxime—Erythema multiforme—Dactinomycin—germ cell cancer	0.00403	0.00443	CcSEcCtD
Cefuroxime—Cramp muscle—Etoposide—germ cell cancer	0.00401	0.00441	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00401	0.00441	CcSEcCtD
Cefuroxime—Pancytopenia—Cisplatin—germ cell cancer	0.00399	0.00439	CcSEcCtD
Cefuroxime—Erythema—Bleomycin—germ cell cancer	0.00398	0.00437	CcSEcCtD
Cefuroxime—Haemoglobin—Ifosfamide—germ cell cancer	0.00392	0.00431	CcSEcCtD
Cefuroxime—SLC15A2—retina—germ cell cancer	0.00392	0.0434	CbGeAlD
Cefuroxime—Hepatitis—Ifosfamide—germ cell cancer	0.0039	0.00429	CcSEcCtD
Cefuroxime—Haemorrhage—Ifosfamide—germ cell cancer	0.0039	0.00429	CcSEcCtD
Cefuroxime—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.00389	0.00427	CcSEcCtD
Cefuroxime—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00386	0.00424	CcSEcCtD
Cefuroxime—Urethral disorder—Ifosfamide—germ cell cancer	0.00383	0.00421	CcSEcCtD
Cefuroxime—Chills—Dactinomycin—germ cell cancer	0.00382	0.0042	CcSEcCtD
Cefuroxime—Thrombocytopenia—Vinblastine—germ cell cancer	0.00376	0.00414	CcSEcCtD
Cefuroxime—Erythema—Dactinomycin—germ cell cancer	0.00371	0.00408	CcSEcCtD
Cefuroxime—Erythema multiforme—Ifosfamide—germ cell cancer	0.00369	0.00406	CcSEcCtD
Cefuroxime—Renal failure—Cisplatin—germ cell cancer	0.00369	0.00405	CcSEcCtD
Cefuroxime—Vaginal inflammation—Methotrexate—germ cell cancer	0.00368	0.00404	CcSEcCtD
Cefuroxime—Anorexia—Vinblastine—germ cell cancer	0.00366	0.00403	CcSEcCtD
Cefuroxime—Pancytopenia—Etoposide—germ cell cancer	0.00366	0.00402	CcSEcCtD
Cefuroxime—Stomatitis—Cisplatin—germ cell cancer	0.00365	0.00402	CcSEcCtD
Cefuroxime—SLC15A1—endocrine gland—germ cell cancer	0.00364	0.0403	CbGeAlD
Cefuroxime—SLC15A2—telencephalon—germ cell cancer	0.00361	0.0399	CbGeAlD
Cefuroxime—Neutropenia—Etoposide—germ cell cancer	0.0036	0.00396	CcSEcCtD
Cefuroxime—Leukopenia—Bleomycin—germ cell cancer	0.00356	0.00391	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00355	0.0039	CcSEcCtD
Cefuroxime—Angiopathy—Ifosfamide—germ cell cancer	0.00354	0.00389	CcSEcCtD
Cefuroxime—Immune system disorder—Ifosfamide—germ cell cancer	0.00353	0.00388	CcSEcCtD
Cefuroxime—Chills—Ifosfamide—germ cell cancer	0.0035	0.00385	CcSEcCtD
Cefuroxime—Vaginal infection—Methotrexate—germ cell cancer	0.00347	0.00382	CcSEcCtD
Cefuroxime—Cough—Bleomycin—germ cell cancer	0.00347	0.00381	CcSEcCtD
Cefuroxime—Aplastic anaemia—Methotrexate—germ cell cancer	0.00345	0.0038	CcSEcCtD
Cefuroxime—Infestation NOS—Etoposide—germ cell cancer	0.00343	0.00378	CcSEcCtD
Cefuroxime—Infestation—Etoposide—germ cell cancer	0.00343	0.00378	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.0034	0.00374	CcSEcCtD
Cefuroxime—Erythema—Ifosfamide—germ cell cancer	0.0034	0.00374	CcSEcCtD
Cefuroxime—Chest pain—Bleomycin—germ cell cancer	0.00339	0.00372	CcSEcCtD
Cefuroxime—Renal failure—Etoposide—germ cell cancer	0.00338	0.00371	CcSEcCtD
Cefuroxime—Jaundice—Etoposide—germ cell cancer	0.00335	0.00368	CcSEcCtD
Cefuroxime—Stomatitis—Etoposide—germ cell cancer	0.00335	0.00368	CcSEcCtD
Cefuroxime—Decreased appetite—Vinblastine—germ cell cancer	0.00334	0.00367	CcSEcCtD
Cefuroxime—Mouth ulceration—Methotrexate—germ cell cancer	0.00332	0.00365	CcSEcCtD
Cefuroxime—Urinary tract disorder—Cisplatin—germ cell cancer	0.00332	0.00365	CcSEcCtD
Cefuroxime—Leukopenia—Dactinomycin—germ cell cancer	0.00332	0.00365	CcSEcCtD
Cefuroxime—Urethral disorder—Cisplatin—germ cell cancer	0.0033	0.00363	CcSEcCtD
Cefuroxime—Pain—Vinblastine—germ cell cancer	0.00329	0.00361	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Etoposide—germ cell cancer	0.00325	0.00357	CcSEcCtD
Cefuroxime—Anaphylactic shock—Bleomycin—germ cell cancer	0.00325	0.00357	CcSEcCtD
Cefuroxime—Agranulocytosis—Etoposide—germ cell cancer	0.0032	0.00352	CcSEcCtD
Cefuroxime—Thrombocytopenia—Bleomycin—germ cell cancer	0.00318	0.00349	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00314	0.00345	CcSEcCtD
Cefuroxime—Agitation—Ifosfamide—germ cell cancer	0.00312	0.00343	CcSEcCtD
Cefuroxime—Angioedema—Ifosfamide—germ cell cancer	0.0031	0.00341	CcSEcCtD
Cefuroxime—Anorexia—Bleomycin—germ cell cancer	0.00309	0.0034	CcSEcCtD
Cefuroxime—Thrombophlebitis—Methotrexate—germ cell cancer	0.00308	0.00339	CcSEcCtD
Cefuroxime—Urinary tract disorder—Etoposide—germ cell cancer	0.00304	0.00335	CcSEcCtD
Cefuroxime—Leukopenia—Ifosfamide—germ cell cancer	0.00304	0.00334	CcSEcCtD
Cefuroxime—Immune system disorder—Cisplatin—germ cell cancer	0.00304	0.00334	CcSEcCtD
Cefuroxime—Abdominal pain—Vinblastine—germ cell cancer	0.00304	0.00334	CcSEcCtD
Cefuroxime—Urethral disorder—Etoposide—germ cell cancer	0.00302	0.00332	CcSEcCtD
Cefuroxime—Palpitations—Ifosfamide—germ cell cancer	0.003	0.0033	CcSEcCtD
Cefuroxime—Cough—Ifosfamide—germ cell cancer	0.00297	0.00326	CcSEcCtD
Cefuroxime—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00296	0.00326	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00296	0.00325	CcSEcCtD
Cefuroxime—Convulsion—Ifosfamide—germ cell cancer	0.00294	0.00324	CcSEcCtD
Cefuroxime—SLC15A2—pituitary gland—germ cell cancer	0.00294	0.0325	CbGeAlD
Cefuroxime—Erythema—Cisplatin—germ cell cancer	0.00293	0.00322	CcSEcCtD
Cefuroxime—Erythema multiforme—Etoposide—germ cell cancer	0.00292	0.0032	CcSEcCtD
Cefuroxime—Dyspnoea—Bleomycin—germ cell cancer	0.00289	0.00318	CcSEcCtD
Cefuroxime—Arthralgia—Ifosfamide—germ cell cancer	0.00289	0.00318	CcSEcCtD
Cefuroxime—Chest pain—Ifosfamide—germ cell cancer	0.00289	0.00318	CcSEcCtD
Cefuroxime—Flatulence—Cisplatin—germ cell cancer	0.00289	0.00317	CcSEcCtD
Cefuroxime—Anorexia—Dactinomycin—germ cell cancer	0.00288	0.00317	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00287	0.00316	CcSEcCtD
Cefuroxime—SLC15A2—medulla oblongata—germ cell cancer	0.00283	0.0314	CbGeAlD
Cefuroxime—Hypersensitivity—Vinblastine—germ cell cancer	0.00283	0.00311	CcSEcCtD
Cefuroxime—Decreased appetite—Bleomycin—germ cell cancer	0.00282	0.0031	CcSEcCtD
Cefuroxime—Muscle spasms—Cisplatin—germ cell cancer	0.00282	0.0031	CcSEcCtD
Cefuroxime—Angiopathy—Etoposide—germ cell cancer	0.0028	0.00307	CcSEcCtD
Cefuroxime—Immune system disorder—Etoposide—germ cell cancer	0.00278	0.00306	CcSEcCtD
Cefuroxime—Pain—Bleomycin—germ cell cancer	0.00277	0.00305	CcSEcCtD
Cefuroxime—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00277	0.00305	CcSEcCtD
Cefuroxime—Chills—Etoposide—germ cell cancer	0.00277	0.00304	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00276	0.00303	CcSEcCtD
Cefuroxime—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00272	0.00298	CcSEcCtD
Cefuroxime—Skin disorder—Ifosfamide—germ cell cancer	0.00269	0.00296	CcSEcCtD
Cefuroxime—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00268	0.00295	CcSEcCtD
Cefuroxime—Anorexia—Ifosfamide—germ cell cancer	0.00264	0.00291	CcSEcCtD
Cefuroxime—Decreased appetite—Dactinomycin—germ cell cancer	0.00263	0.00289	CcSEcCtD
Cefuroxime—Diarrhoea—Vinblastine—germ cell cancer	0.00263	0.00289	CcSEcCtD
Cefuroxime—SLC15A2—adrenal gland—germ cell cancer	0.00262	0.0291	CbGeAlD
Cefuroxime—Leukopenia—Cisplatin—germ cell cancer	0.00262	0.00288	CcSEcCtD
Cefuroxime—SLC15A2—midbrain—germ cell cancer	0.00259	0.0287	CbGeAlD
Cefuroxime—Pain—Dactinomycin—germ cell cancer	0.00259	0.00284	CcSEcCtD
Cefuroxime—Muscle spasms—Etoposide—germ cell cancer	0.00258	0.00284	CcSEcCtD
Cefuroxime—Urticaria—Bleomycin—germ cell cancer	0.00258	0.00283	CcSEcCtD
Cefuroxime—Body temperature increased—Bleomycin—germ cell cancer	0.00257	0.00282	CcSEcCtD
Cefuroxime—Irritability—Methotrexate—germ cell cancer	0.00255	0.0028	CcSEcCtD
Cefuroxime—Dizziness—Vinblastine—germ cell cancer	0.00254	0.00279	CcSEcCtD
Cefuroxime—Convulsion—Cisplatin—germ cell cancer	0.00254	0.00279	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00253	0.00278	CcSEcCtD
Cefuroxime—SLC15A2—spinal cord—germ cell cancer	0.00253	0.028	CbGeAlD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00248	0.00272	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00247	0.00272	CcSEcCtD
Cefuroxime—Dyspnoea—Ifosfamide—germ cell cancer	0.00247	0.00272	CcSEcCtD
Cefuroxime—Somnolence—Ifosfamide—germ cell cancer	0.00247	0.00271	CcSEcCtD
Cefuroxime—SLC15A2—female gonad—germ cell cancer	0.00245	0.0271	CbGeAlD
Cefuroxime—Vomiting—Vinblastine—germ cell cancer	0.00244	0.00269	CcSEcCtD
Cefuroxime—Decreased appetite—Ifosfamide—germ cell cancer	0.00241	0.00265	CcSEcCtD
Cefuroxime—Headache—Vinblastine—germ cell cancer	0.00241	0.00265	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.0024	0.00264	CcSEcCtD
Cefuroxime—Leukopenia—Etoposide—germ cell cancer	0.0024	0.00264	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00239	0.00263	CcSEcCtD
Cefuroxime—Abdominal pain—Dactinomycin—germ cell cancer	0.00239	0.00263	CcSEcCtD
Cefuroxime—Body temperature increased—Dactinomycin—germ cell cancer	0.00239	0.00263	CcSEcCtD
Cefuroxime—Anaphylactic shock—Cisplatin—germ cell cancer	0.00239	0.00263	CcSEcCtD
Cefuroxime—Hypersensitivity—Bleomycin—germ cell cancer	0.00239	0.00263	CcSEcCtD
Cefuroxime—Pain—Ifosfamide—germ cell cancer	0.00237	0.00261	CcSEcCtD
Cefuroxime—Cough—Etoposide—germ cell cancer	0.00234	0.00257	CcSEcCtD
Cefuroxime—Thrombocytopenia—Cisplatin—germ cell cancer	0.00234	0.00257	CcSEcCtD
Cefuroxime—Tachycardia—Cisplatin—germ cell cancer	0.00233	0.00256	CcSEcCtD
Cefuroxime—Convulsion—Etoposide—germ cell cancer	0.00233	0.00256	CcSEcCtD
Cefuroxime—Skin disorder—Cisplatin—germ cell cancer	0.00232	0.00255	CcSEcCtD
Cefuroxime—Hyperhidrosis—Cisplatin—germ cell cancer	0.00231	0.00254	CcSEcCtD
Cefuroxime—Pruritus—Bleomycin—germ cell cancer	0.0023	0.00252	CcSEcCtD
Cefuroxime—Chest pain—Etoposide—germ cell cancer	0.00228	0.00251	CcSEcCtD
Cefuroxime—Eosinophilia—Methotrexate—germ cell cancer	0.00228	0.00251	CcSEcCtD
Cefuroxime—Nausea—Vinblastine—germ cell cancer	0.00228	0.00251	CcSEcCtD
Cefuroxime—Anorexia—Cisplatin—germ cell cancer	0.00228	0.00251	CcSEcCtD
Cefuroxime—SLC15A2—endocrine gland—germ cell cancer	0.00227	0.0252	CbGeAlD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00227	0.00249	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00227	0.00249	CcSEcCtD
Cefuroxime—SLC15A2—head—germ cell cancer	0.00225	0.0249	CbGeAlD
Cefuroxime—Hypersensitivity—Dactinomycin—germ cell cancer	0.00223	0.00245	CcSEcCtD
Cefuroxime—Urticaria—Ifosfamide—germ cell cancer	0.0022	0.00242	CcSEcCtD
Cefuroxime—Abdominal pain—Ifosfamide—germ cell cancer	0.00219	0.00241	CcSEcCtD
Cefuroxime—Body temperature increased—Ifosfamide—germ cell cancer	0.00219	0.00241	CcSEcCtD
Cefuroxime—Pancytopenia—Methotrexate—germ cell cancer	0.00219	0.00241	CcSEcCtD
Cefuroxime—Anaphylactic shock—Etoposide—germ cell cancer	0.00219	0.00241	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00218	0.00239	CcSEcCtD
Cefuroxime—SLC15A2—testis—germ cell cancer	0.00217	0.024	CbGeAlD
Cefuroxime—Neutropenia—Methotrexate—germ cell cancer	0.00216	0.00237	CcSEcCtD
Cefuroxime—Dysuria—Methotrexate—germ cell cancer	0.00216	0.00237	CcSEcCtD
Cefuroxime—Thrombocytopenia—Etoposide—germ cell cancer	0.00214	0.00236	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00214	0.00236	CcSEcCtD
Cefuroxime—Tachycardia—Etoposide—germ cell cancer	0.00214	0.00235	CcSEcCtD
Cefuroxime—Dyspnoea—Cisplatin—germ cell cancer	0.00213	0.00234	CcSEcCtD
Cefuroxime—Skin disorder—Etoposide—germ cell cancer	0.00213	0.00234	CcSEcCtD
Cefuroxime—Hyperhidrosis—Etoposide—germ cell cancer	0.00212	0.00233	CcSEcCtD
Cefuroxime—Anorexia—Etoposide—germ cell cancer	0.00209	0.0023	CcSEcCtD
Cefuroxime—Decreased appetite—Cisplatin—germ cell cancer	0.00208	0.00228	CcSEcCtD
Cefuroxime—Diarrhoea—Dactinomycin—germ cell cancer	0.00207	0.00228	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00206	0.00227	CcSEcCtD
Cefuroxime—Vomiting—Bleomycin—germ cell cancer	0.00206	0.00227	CcSEcCtD
Cefuroxime—Infestation NOS—Methotrexate—germ cell cancer	0.00206	0.00226	CcSEcCtD
Cefuroxime—Infestation—Methotrexate—germ cell cancer	0.00206	0.00226	CcSEcCtD
Cefuroxime—Drowsiness—Methotrexate—germ cell cancer	0.00206	0.00226	CcSEcCtD
Cefuroxime—Rash—Bleomycin—germ cell cancer	0.00205	0.00225	CcSEcCtD
Cefuroxime—Pain—Cisplatin—germ cell cancer	0.00204	0.00225	CcSEcCtD
Cefuroxime—Dermatitis—Bleomycin—germ cell cancer	0.00204	0.00225	CcSEcCtD
Cefuroxime—Hypersensitivity—Ifosfamide—germ cell cancer	0.00204	0.00225	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00204	0.00224	CcSEcCtD
Cefuroxime—Renal failure—Methotrexate—germ cell cancer	0.00202	0.00222	CcSEcCtD
Cefuroxime—Stomatitis—Methotrexate—germ cell cancer	0.00201	0.0022	CcSEcCtD
Cefuroxime—SLC15A2—cerebellum—germ cell cancer	0.002	0.0222	CbGeAlD
Cefuroxime—Sweating—Methotrexate—germ cell cancer	0.00197	0.00217	CcSEcCtD
Cefuroxime—Pruritus—Ifosfamide—germ cell cancer	0.00196	0.00216	CcSEcCtD
Cefuroxime—Dyspnoea—Etoposide—germ cell cancer	0.00195	0.00215	CcSEcCtD
Cefuroxime—Somnolence—Etoposide—germ cell cancer	0.00195	0.00214	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00195	0.00214	CcSEcCtD
Cefuroxime—Nausea—Bleomycin—germ cell cancer	0.00193	0.00212	CcSEcCtD
Cefuroxime—Vomiting—Dactinomycin—germ cell cancer	0.00192	0.00212	CcSEcCtD
Cefuroxime—Agranulocytosis—Methotrexate—germ cell cancer	0.00192	0.00211	CcSEcCtD
Cefuroxime—Rash—Dactinomycin—germ cell cancer	0.00191	0.0021	CcSEcCtD
Cefuroxime—Decreased appetite—Etoposide—germ cell cancer	0.0019	0.00209	CcSEcCtD
Cefuroxime—Diarrhoea—Ifosfamide—germ cell cancer	0.0019	0.00209	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00189	0.00208	CcSEcCtD
Cefuroxime—Body temperature increased—Cisplatin—germ cell cancer	0.00189	0.00208	CcSEcCtD
Cefuroxime—Pain—Etoposide—germ cell cancer	0.00187	0.00206	CcSEcCtD
Cefuroxime—Haemoglobin—Methotrexate—germ cell cancer	0.00186	0.00204	CcSEcCtD
Cefuroxime—Haemorrhage—Methotrexate—germ cell cancer	0.00185	0.00203	CcSEcCtD
Cefuroxime—Hepatitis—Methotrexate—germ cell cancer	0.00185	0.00203	CcSEcCtD
Cefuroxime—Dizziness—Ifosfamide—germ cell cancer	0.00183	0.00202	CcSEcCtD
Cefuroxime—Urinary tract disorder—Methotrexate—germ cell cancer	0.00182	0.002	CcSEcCtD
Cefuroxime—Urethral disorder—Methotrexate—germ cell cancer	0.00181	0.00199	CcSEcCtD
Cefuroxime—Nausea—Dactinomycin—germ cell cancer	0.0018	0.00198	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Etoposide—germ cell cancer	0.00179	0.00197	CcSEcCtD
Cefuroxime—Vomiting—Ifosfamide—germ cell cancer	0.00176	0.00194	CcSEcCtD
Cefuroxime—Hypersensitivity—Cisplatin—germ cell cancer	0.00176	0.00194	CcSEcCtD
Cefuroxime—Rash—Ifosfamide—germ cell cancer	0.00175	0.00192	CcSEcCtD
Cefuroxime—Dermatitis—Ifosfamide—germ cell cancer	0.00175	0.00192	CcSEcCtD
Cefuroxime—Erythema multiforme—Methotrexate—germ cell cancer	0.00175	0.00192	CcSEcCtD
Cefuroxime—Urticaria—Etoposide—germ cell cancer	0.00174	0.00191	CcSEcCtD
Cefuroxime—Abdominal pain—Etoposide—germ cell cancer	0.00173	0.0019	CcSEcCtD
Cefuroxime—Body temperature increased—Etoposide—germ cell cancer	0.00173	0.0019	CcSEcCtD
Cefuroxime—Angiopathy—Methotrexate—germ cell cancer	0.00168	0.00184	CcSEcCtD
Cefuroxime—Immune system disorder—Methotrexate—germ cell cancer	0.00167	0.00183	CcSEcCtD
Cefuroxime—Chills—Methotrexate—germ cell cancer	0.00166	0.00182	CcSEcCtD
Cefuroxime—Nausea—Ifosfamide—germ cell cancer	0.00165	0.00181	CcSEcCtD
Cefuroxime—Diarrhoea—Cisplatin—germ cell cancer	0.00164	0.0018	CcSEcCtD
Cefuroxime—SLC15A2—brain—germ cell cancer	0.00163	0.018	CbGeAlD
Cefuroxime—Hypersensitivity—Etoposide—germ cell cancer	0.00161	0.00177	CcSEcCtD
Cefuroxime—Erythema—Methotrexate—germ cell cancer	0.00161	0.00177	CcSEcCtD
Cefuroxime—SLC15A2—lymph node—germ cell cancer	0.00157	0.0174	CbGeAlD
Cefuroxime—Pruritus—Etoposide—germ cell cancer	0.00155	0.0017	CcSEcCtD
Cefuroxime—Vomiting—Cisplatin—germ cell cancer	0.00152	0.00167	CcSEcCtD
Cefuroxime—Rash—Cisplatin—germ cell cancer	0.00151	0.00166	CcSEcCtD
Cefuroxime—Dermatitis—Cisplatin—germ cell cancer	0.00151	0.00166	CcSEcCtD
Cefuroxime—Diarrhoea—Etoposide—germ cell cancer	0.0015	0.00165	CcSEcCtD
Cefuroxime—Dizziness—Etoposide—germ cell cancer	0.00145	0.00159	CcSEcCtD
Cefuroxime—Leukopenia—Methotrexate—germ cell cancer	0.00144	0.00158	CcSEcCtD
Cefuroxime—Nausea—Cisplatin—germ cell cancer	0.00142	0.00156	CcSEcCtD
Cefuroxime—Cough—Methotrexate—germ cell cancer	0.0014	0.00154	CcSEcCtD
Cefuroxime—Convulsion—Methotrexate—germ cell cancer	0.00139	0.00153	CcSEcCtD
Cefuroxime—Vomiting—Etoposide—germ cell cancer	0.00139	0.00153	CcSEcCtD
Cefuroxime—Rash—Etoposide—germ cell cancer	0.00138	0.00152	CcSEcCtD
Cefuroxime—Dermatitis—Etoposide—germ cell cancer	0.00138	0.00152	CcSEcCtD
Cefuroxime—Headache—Etoposide—germ cell cancer	0.00137	0.00151	CcSEcCtD
Cefuroxime—Arthralgia—Methotrexate—germ cell cancer	0.00137	0.0015	CcSEcCtD
Cefuroxime—Chest pain—Methotrexate—germ cell cancer	0.00137	0.0015	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00136	0.00149	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methotrexate—germ cell cancer	0.00131	0.00144	CcSEcCtD
Cefuroxime—Nausea—Etoposide—germ cell cancer	0.0013	0.00143	CcSEcCtD
Cefuroxime—Thrombocytopenia—Methotrexate—germ cell cancer	0.00128	0.00141	CcSEcCtD
Cefuroxime—Skin disorder—Methotrexate—germ cell cancer	0.00127	0.0014	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methotrexate—germ cell cancer	0.00127	0.00139	CcSEcCtD
Cefuroxime—Anorexia—Methotrexate—germ cell cancer	0.00125	0.00137	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.0012	0.00131	CcSEcCtD
Cefuroxime—Dyspnoea—Methotrexate—germ cell cancer	0.00117	0.00129	CcSEcCtD
Cefuroxime—Somnolence—Methotrexate—germ cell cancer	0.00117	0.00128	CcSEcCtD
Cefuroxime—Dyspepsia—Methotrexate—germ cell cancer	0.00115	0.00127	CcSEcCtD
Cefuroxime—Decreased appetite—Methotrexate—germ cell cancer	0.00114	0.00125	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00113	0.00125	CcSEcCtD
Cefuroxime—Pain—Methotrexate—germ cell cancer	0.00112	0.00123	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00107	0.00118	CcSEcCtD
Cefuroxime—Urticaria—Methotrexate—germ cell cancer	0.00104	0.00115	CcSEcCtD
Cefuroxime—Abdominal pain—Methotrexate—germ cell cancer	0.00104	0.00114	CcSEcCtD
Cefuroxime—Body temperature increased—Methotrexate—germ cell cancer	0.00104	0.00114	CcSEcCtD
Cefuroxime—Hypersensitivity—Methotrexate—germ cell cancer	0.000967	0.00106	CcSEcCtD
Cefuroxime—Pruritus—Methotrexate—germ cell cancer	0.000928	0.00102	CcSEcCtD
Cefuroxime—Diarrhoea—Methotrexate—germ cell cancer	0.000898	0.000987	CcSEcCtD
Cefuroxime—Dizziness—Methotrexate—germ cell cancer	0.000868	0.000954	CcSEcCtD
Cefuroxime—Vomiting—Methotrexate—germ cell cancer	0.000834	0.000917	CcSEcCtD
Cefuroxime—Rash—Methotrexate—germ cell cancer	0.000827	0.000909	CcSEcCtD
Cefuroxime—Dermatitis—Methotrexate—germ cell cancer	0.000826	0.000908	CcSEcCtD
Cefuroxime—Headache—Methotrexate—germ cell cancer	0.000822	0.000903	CcSEcCtD
Cefuroxime—Nausea—Methotrexate—germ cell cancer	0.000779	0.000857	CcSEcCtD
